Beta glucan vs bacterial infections - continuous daily use of yeast-derived beta glucan is questioned.
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D001424:Bacterial Infections / Q000378:metabolism / Q000628:therapy*; D000529:Complementary Therapies; D016207:Cytokines / Q000378:metabolism; D003602:Cytotoxicity, Immunologic; D004137:Dinitrochlorobenzene / Q000008:administration & dosage; D005936:Glucans / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007111:Immunity, Cellular; D007694:Killer Cells, Natural / Q000276:immunology; D051379:Mice; D015003:Yeasts / Q000276:immunology
D000276:Adjuvants, Immunologic; D016207:Cytokines; D004137:Dinitrochlorobenzene; D005936:Glucans